Lithotripter shock waves with cavitation nucleation agents produce tumor growth reduction and gene transfer in vivo
- 1 October 2002
- journal article
- Published by Elsevier in Japanese Journal of Clinical Oncology
- Vol. 28 (10), 1343-1348
- https://doi.org/10.1016/s0301-5629(02)00572-0
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Pharmacokinetics of plasmid DNA in the rat.Pharmaceutical Research, 2001
- Ultrasound enhancement of cationic lipid-mediated gene transfer to primary tumors following systemic administrationGene Therapy, 2000
- Acoustic droplet vaporization for therapeutic and diagnostic applicationsJapanese Journal of Clinical Oncology, 2000
- In vitro and in vivo transfection of plasmid DNA in the Dunning prostate tumor R3327-AT1 is enhanced by focused ultrasoundGene Therapy, 2000
- Cavitation nucleation agents for nonthermal ultrasound therapyThe Journal of the Acoustical Society of America, 2000
- Ultrasonic enhancement of gene transfection in murine melanoma tumorsJapanese Journal of Clinical Oncology, 1999
- CONSEQUENCES OF LITHOTRIPTER SHOCKWAVE INTERACTION WITH GAS BODY CONTRAST AGENT IN MOUSE INTESTINEJournal of Urology, 1999
- Dissolution of multicomponent microbubbles in the bloodstream: 1. theoryJapanese Journal of Clinical Oncology, 1998
- The cavitation threshold of human tissue exposed to 0.2-MHz pulsed ultrasound: Preliminary measurements based on a study of clinical lithotripsyJapanese Journal of Clinical Oncology, 1995
- Medical applications and bioeffects of extracorporeal shock wavesShock Waves, 1994